Trial NCT02144012

View at ClinicalTrials.gov 
Org. Study IDs: YO28405

Last trial update was posted on 2017-03-07

MeSH Interventions

Ado-Trastuzumab Emtansine Docetaxel Maytansine Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

Metastatic Breast Cancer

Stopping Reasons

N/A

Limitations And Caveats

Due to early termination of the study only limited data from a small subset (49) of the originally planned study population size (561) are available and were too limited to perform originally planned efficacy analyses as specified in the protocol.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID